BusinessEndonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical DeviceBy Nasdaq OMXFeb 12, 2018, 2:32 PM UTC
BusinessProteon Therapeutics Announces First Patient Dosed in Phase 1 Study Evaluating Vonapanitase for the Treatment of Peripheral Artery Disease Below the KneeBy Nasdaq OMXNov 10, 2016, 1:00 PM UTC
BusinessProteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery DiseaseBy Nasdaq OMXApr 13, 2016, 12:00 PM UTC
